DK1572715T3 - Steroidforbindelser med antitumor-aktivitet - Google Patents

Steroidforbindelser med antitumor-aktivitet

Info

Publication number
DK1572715T3
DK1572715T3 DK03789347T DK03789347T DK1572715T3 DK 1572715 T3 DK1572715 T3 DK 1572715T3 DK 03789347 T DK03789347 T DK 03789347T DK 03789347 T DK03789347 T DK 03789347T DK 1572715 T3 DK1572715 T3 DK 1572715T3
Authority
DK
Denmark
Prior art keywords
steroid compounds
present
steroid
relates
antitumor activity
Prior art date
Application number
DK03789347T
Other languages
Danish (da)
English (en)
Inventor
Quaquebeke Eric Van
Laurent Ingrassia
Janique Dewelle
Robert Kiss
Jean-Claude Braekman
Francis Darro
Original Assignee
Unibioscreen Sa
Univ Bruxelles
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unibioscreen Sa, Univ Bruxelles filed Critical Unibioscreen Sa
Application granted granted Critical
Publication of DK1572715T3 publication Critical patent/DK1572715T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
DK03789347T 2002-12-18 2003-12-18 Steroidforbindelser med antitumor-aktivitet DK1572715T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02447257 2002-12-18
US43583402P 2002-12-20 2002-12-20
PCT/EP2003/014567 WO2004055039A1 (en) 2002-12-18 2003-12-18 Steroid compounds with anti-tumor activity

Publications (1)

Publication Number Publication Date
DK1572715T3 true DK1572715T3 (da) 2007-04-02

Family

ID=32598801

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03789347T DK1572715T3 (da) 2002-12-18 2003-12-18 Steroidforbindelser med antitumor-aktivitet

Country Status (15)

Country Link
US (1) US20060149045A1 (de)
EP (1) EP1572715B1 (de)
JP (1) JP2006511544A (de)
CN (1) CN100402546C (de)
AT (1) ATE346080T1 (de)
AU (1) AU2003293943B2 (de)
CA (1) CA2509283A1 (de)
DE (1) DE60309926T2 (de)
DK (1) DK1572715T3 (de)
ES (1) ES2277138T3 (de)
HK (1) HK1085744A1 (de)
MX (1) MXPA05006378A (de)
PT (1) PT1572715E (de)
WO (1) WO2004055039A1 (de)
ZA (1) ZA200504777B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101352635B1 (ko) * 2011-12-29 2014-01-20 연세대학교 산학협력단 신규 혈관누출 차단제
EP3162875B1 (de) * 2015-10-30 2018-05-23 Merck Patent GmbH Polymerisierbare verbindungen und verwendung davon in flüssigkristallanzeigevorrichtungen
US10434106B2 (en) * 2017-05-19 2019-10-08 Warsaw Orthopedic, Inc. Oxysterol-statin compounds for bone growth

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3584050B2 (ja) * 1993-05-14 2004-11-04 株式会社医薬分子設計研究所 ステロイド化合物

Also Published As

Publication number Publication date
US20060149045A1 (en) 2006-07-06
ATE346080T1 (de) 2006-12-15
CA2509283A1 (en) 2004-07-01
DE60309926T2 (de) 2007-09-13
AU2003293943A1 (en) 2004-07-09
EP1572715B1 (de) 2006-11-22
CN100402546C (zh) 2008-07-16
PT1572715E (pt) 2007-01-31
DE60309926D1 (de) 2007-01-04
EP1572715A1 (de) 2005-09-14
JP2006511544A (ja) 2006-04-06
CN1745090A (zh) 2006-03-08
ZA200504777B (en) 2006-04-26
HK1085744A1 (en) 2006-09-01
AU2003293943B2 (en) 2009-08-13
MXPA05006378A (es) 2006-02-08
ES2277138T3 (es) 2007-07-01
WO2004055039A1 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
MX2007002398A (es) Nuevas composiciones farmaceuticas para el tratamiento de cancer.
TW200609227A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
GB0112348D0 (en) Compounds
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
HK1091481A1 (en) Therapeutic agents useful for treating pain
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MX2007004955A (es) Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente.
EP1819227A4 (de) Pharmazeutische formulierungen von decitabin
BR0309343A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
IL151628A0 (en) Combination therapies with vascular damaging activity
BR0311491A (pt) Composto, composição farmacêutica, uso de um composto, e, método terapêutico para tratar câncer em um mamìfero
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MY145041A (en) Pyrazolopyrimidine derivatives
MXPA05010020A (es) Derivados de oxamida.
TW200719903A (en) Compositions for the treatment of neoplasms
AU2003216109A1 (en) Therapeutic composition for treatment of cancer by arginine depletion
HK1085744A1 (en) Steroid compounds with anti-tumor activity
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
ATE393624T1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs